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ABSTRACT: Melting temperatures and enthalpies of fusion have been determined by 
differential scanning calorimetry (DSC) for two polymorphs of the drug tolbutamide: FIH and 
FV. Heat capacities have been determined by temperature-modulated DSC for four 
polymorphs: FIL, FIH, FII, FV, and for the supercooled melt. The enthalpy of fusion of FII at 
its melting point has been estimated from the enthalpy of transition of FII into FIH through a 
thermodynamic cycle. Calorimetric data has been used to derive a quantitative polymorphic 
stability relationship between these four polymorphs, showing that FII is the stable polymorph 
below approx. 333 K, above which temperature FIH is the stable form up to its melting point. 
The relative stability of FV is well below the other polymorphs. The previously reported kinetic 
reversibility of the transformation between FIL and FIH has been verified using in situ Raman 
spectroscopy. The solid-liquid solubility of FII has been gravimetrically determined in five pure 
organic solvents (methanol, 1-propanol, ethyl acetate, acetonitrile and toluene) over the 
temperature range 278 K – 323 K. The ideal solubility has been estimated from calorimetric 
data, and solution activity coefficients at saturation in the five solvents determined. All 
solutions show positive deviation from Raoult’s law, and all van’t Hoff plots of solubility data 
are non-linear. The solubility in toluene is well below that observed in the other investigated 
solvents. Solubility data has been correlated and extrapolated to the melting point using a semi-
empirical regression model. 
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INTRODUCTION 
The solid-liquid solubility of a crystalline, pharmaceutically active compound is a very 
important property, directly affecting its therapeutic effectiveness. Knowledge of the 
temperature dependence of the solubility of different solid forms of a drug is a prerequisite for 
the successful design of suitable dosage forms and optimization of the manufacturing process. 
The solubility is particularly important in crystallization processes, where it is a key to 
controlling the supersaturation, the particle size, shape and yield, as well as polymorphic form. 
The prevalence among organic compounds of polymorphs, having the same elemental 
composition but different crystal structures, is well documented. There is a vast number of 
physicochemical properties that can differ between polymorphs,[1] most importantly 
solubility[2] and dissolution rate (and thence bioavailability of an API,) and physical and 
chemical stability. As a consequence of this, there are strict regulations for identification of 
possible polymorphs and careful process control.[3] Another aspect is the fact that the majority 
of drug candidates are abandoned at an early stage, frequently because of poor solubility.[4] 
Finally, an important role of polymorphs in the pharmaceutical industry is that they can form 
the basis for intellectual property rights.[5] A thorough investigation into the polymorphism of 
a drug substance, including an evaluation of the thermodynamic stability relationship of the 
different solid forms, is thus always called for.  
Tolbutamide (N-[(Butylamino)carbonyl]-4-methylbenzenesulfonamide; 1-butyl-3-(4-methyl- 
phenylsulfonyl) urea; CAS number 64-77-7) is a first-generation sulfonylurea oral 
hypoglycemic drug compound, which has been used e.g. under the market name Orinase in the 
treatment of type II diabetes as a complement to a controlled diet. It acts through stimulating 
pancreatic insulin secretion.[6] The molecular structure of tolbutamide is provided as supporting 
information. Because of its significant conformational flexibility, tolbutamide has a high 
propensity for polymorphism. At least six polymorphs of tolbutamide are reported to exist.[7,8] 
At ambient conditions FII is reported to be the stable solid form, followed by FIL and then the 
more metastable forms FIII and FIV.[7] FV is reported to be 1D-isostructural with FIV and to 
rapidly convert into FIL at ambient conditions.[8] On heating the pure solid, at approx. 313 K 
FIL is reported to transform reversibly into FIH.[7] The structural similarity of FIL and FIH, and 
the reported kinetic reversibility of the interconversion, are the reasons for the peculiar naming 
of these two polymorphs. At higher temperatures FIH is the stable polymorph with a high 
melting point of 401 K.[7] The thermodynamic transition temperature between FII and FIH is 
verified to be below 390 K (the reported melting point of FII) and, based on a comparison of 
solubility data in ethanol, should be located near 353 K.[7] 
In this work, we report the solubility of the low-temperature stable polymorph FII between 278 
K and 313 K in 5 pure organic solvents: methanol, 1-propanol, ethyl acetate, acetonitrile and 
toluene. Based on a comprehensive thermodynamic analysis of calorimetric data, the Gibbs 
energy, enthalpy and entropy of fusion are calculated as functions of temperature for 
polymorphs FIL, FIH, FII and FV, allowing a more comprehensive and accurate establishment 
of the stability relationship than previously reported. By comparing solubility data with the 
activity of pure solid FII, activity coefficients at saturation have been calculated in the five 
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solvents at different temperatures. The activity coefficients and the solubility have been 
modelled using a thermodynamically robust semi-empirical regression model.  
EXPERIMENTAL SECTION 
Materials 
Tolbutamide was obtained from Sigma-Aldrich at a specified mass fraction purity of 99.7% and 
confirmed to be FIL by X-ray powder diffraction (XRPD). Methanol (99.9%), acetonitrile 
(99.9%), ethyl acetate (99.7%) and toluene (99.9%) were obtained from Sigma-Aldrich, and 1-
propanol (99.5%) from VWR. All solvents were used as received with no further purification. 
Preparation of FII 
For preparation of FII, FIL as received from the supplier was partly dissolved in toluene and the 
slurry agitated for 7 days at ambient temperature in a sealed bottle. The solvent was then 
evaporated in a fume hood and the phase identity of the dry powder verified to be pure FII using 
XRPD and Raman spectroscopy. 
Spectroscopic characterization 
Raman spectra were collected using a Kaiser Raman Rxn2 analyser equipped with a 785 nm 
excitation laser and a CCD-based detector. A non-contact optic probe was used to collect 
spectra with a minimum exposure time of 10 s and 5 accumulations over the spectral region of 
1750-200 cm-1. Raman spectra of FIL, FIH and FII are provided as supporting information. 
Thermal analysis 
Differential scanning calorimetry (DSC) analyses were carried out using a TA Instruments 
MDSC 2920. Powder samples (3–8 mg) were encapsulated in hermetically sealed aluminum 
pans, and the furnace was purged with nitrogen gas at a rate of 50 ml min-1. The extrapolated 
onset temperature and associated enthalpy changes of phase transitions were determined using 
a constant heating rate of 5 K min-1. A subset of samples were cooled and reheated once after 
melting. Heat capacity measurements were conducted using the same instrument operated in 
temperature-modulated mode. A modulation period of 100 s and an amplitude of 1 K were used, 
with an underlying constant heating rate of 5 K min-1. The heat capacity of the solid was 
measured by heating the solid material until it melted. The heat capacity of the melt was 
obtained by cooling the resulting melt inside the pan to a temperature below the melting point 
without recrystallization occurring, followed by a heating scan of the supercooled melt. 
Calibration of the temperature and the calorimetric response of the instrument was carried out 
according to standard procedure against the melting properties of indium, and the heat capacity 
signal was calibrated against a sapphire sample using a linear function of the temperature. 
Differences in weight between sample and reference pans were limited to ±0.10 mg.  
Solubility measurement 
The solid-liquid solubility was measured using a gravimetric method. Saturated solutions with 
excess crystals were prepared in capped vials. The temperature was controlled using a Grant 
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S26 thermostatic bath equipped with a GR150 control unit (specified temperature stability of 
±0.005 K) and a Grant C2G cooling unit. Agitation of solutions was provided by magnetic stir 
bars, rotated at a rate of 600 min-1 using a 2Mag 60-point submersible stirring plate. Before 
sampling, stirring was switched off to allow excess crystals to settle for approx. 3 h. Samples 
of approx. 5 mL of clear solution were collected from the bulk of each solution using pre-heated 
syringes, and filtered through 0.2 µm PTFE filters into glass vials (50 mm × 25 mm). The vials 
were immediately capped and weighed. The caps were removed and solutions were placed in a 
fume hood for two weeks in order to evaporate all solvent. The vials containing visibly dry 
solids were then further dried in an oven at 50 °C for 24 h. The mass of each vial were recorded 
by repeated weighing, verifying complete dryness. The solution concentration C was 
determined from the masses of the empty vials, the capped vials containing solution, the caps 
and the vials containing the dry solids, according to: 
empty vialcap vialcapped full
empty vialdry vial
mmm
mm
C


          (1)                                                                                                                  
Samples were collected in triplicate from each solution at temperatures ranging from 278 K to 
313 K in increments of 5 K. The solutions were kept under agitation for 24 h before sampling 
at each temperature. All syringes and filters were preheated to the solution temperature prior to 
sampling. The establishment of equilibrium after 24 h was verified within experimental 
limitations in all solvents at 5°C by comparison with concentrations re-measured after 48 h. In 
order to ensure that equilibrium was always attained by dissolution, pure solvents were pre-
cooled to 278 K before solid tolbutamide was added. The specified error of the balance used is 
0.0001 g. The identity of the polymorph present at equilibrium with each sampled solution was 
verified by XRPD, once during solution preparation and again at 313 K after completed 
sampling. 
RESULTS AND DISCUSSION 
Thermodynamic stability relationship of tolbutamide polymorphs 
On heating FIL powder in a DSC pan, it was observed to transform into FIH at 311 K with an 
associated enthalpy change (endothermic) of 2.5 kJ mol-1. Upon further heating, FIH was 
observed to melt at 400 K with an enthalpy of fusion of 27.6 kJ mol-1. On heating FII, an 
unexplained, very faint endotherm (0.1 kJ mol-1) was observed at 311 K, and at 376 K FII 
invariably transformed into FIH with an enthalpy change (endothermic) of 3.1 kJ mol-1. On 
cooling the melt inside the pan it recrystallised at approx. 350 K, and on subsequent heating the 
resulting solid was observed to melt at 376 K with an associated enthalpy of fusion of 19.7 kJ 
mol-1. This new solid was verified to be FV by IR spectroscopy, using a Perkin Elmer Spectrum 
One with an ATR cell, and by comparison with spectra of all the known polymorphs.[8] Typical 
DSC thermograms are shown in Figure 1, and numerical data for the observed phase transitions 
is reported as means of four runs in each case, with associated standard errors, in Table 1. 
The heat capacities of FIL, FIH, FII, FV and the supercooled melt were successfully measured 
over different temperature ranges. Figure 2 shows averaged values of heat capacities together 
with 90% confidence bands. For FV only one scan was carried out. The curves have been 
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truncated at the points where they start to deviate from linear behavior close to the onset of 
phase transitions, and averaged data has been used to fit the coefficients of Eq. 2 (T in units of 
K): 
21 kTkC p             (2) 
Resulting regression coefficients are given in Table 2 together with goodness of fit, and 
experimental heat capacity data is available as supporting information. The FII curve shown in 
Figure 2 has a small peak at 311 K, corresponding to the faint endotherm observed on heating 
FII, Figure 1. The origin of this peak has not been verified, but a likely source is traces of FIL 
in the FII powder (not detected by XRPD or Raman spectroscopy) which transforms into FIH. 
A comparison of the enthalpies of the respective peaks suggests that the FIL content in the FII 
material should be below 5%. The selection of a linear regression equation, in the fitting of 
which data over the temperature range 304 K – 320 K was not used, should render the impact 
of this error negligible. 
The calorimetric data appears to support the reported observation[7] with regard to the stability 
relationship of FIL and FIH. In the DSC pan, the transformation between FIL and FIH repeatedly 
and kinetically reversibly occurred at 311 K. This results in the complete inaccessibility of FIH 
below this temperature and of FIL above it. Indeed, for purposes of a thermodynamic analysis, 
the results suggest that these two phases could be treated as a single polymorph, with 
discontinuous heat capacity, enthalpy and entropy curves but with a continuous Gibbs energy 
curve.  
For further verification of the reversibility of the transformation FIL ↔ FIH, the phenomenon 
was investigated using in situ Raman spectroscopy. FIL crystal powder was placed in a flask 
together with a Raman probe and sealed with Parafilm. The flask was placed in a cryostatic 
bath (Grant GR150 with a C2G cooling unit). The bath temperature was then linearly raised 
and lowered according to a specific program, and Raman spectra recorded regularly (1/min). 
The Raman spectra (available as supporting information) of the two phases are very similar, 
but FIL has increased intensity at some wavenumbers, notably at 1451, 1149 and 960 cm-1 while 
FIH has increased intensity at 1300 and 1122 cm-1. The first three of these peaks were designated 
as indicative of FIL and the latter two as indicative of FIH. The intensities at these respective 
wavenumbers were averaged and normalized for all spectra collected as the sample was heated 
and cooled. The peaks of the transformation events, taken as the points where the two averaged 
intensity values become equal, occur at bath temperatures of approx. 318 K (on heating) and 
314 K (on cooling), respectively. The onset temperatures would show even less hysteresis, but 
are difficult to define. Notably, there is a systematic difference of several K compared to the 
transformation temperature observed using DSC (311 K), which we attribute to the 
experimental setup involving a flask with a probe partly submerged in a water bath. Figures 
showing the normalized intensity profiles and Raman spectra in the fingerprint region during 
the experiment are provided as supporting information. 
The DSC data also verifies that FIH is more stable than FII and FV at high temperatures. 
However, the consistently observed FII→FIH transformation precluded observation of a 
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melting peak of FII. Thirunahari et al.[7] were able to observe the onset of melting prior to 
polymorphic transformation, and report the melting point to be 390 K. An estimate of the 
enthalpy of fusion of FII at this temperature was obtained from the enthalpy of the transition 
FII → FIH, the enthalpy of fusion of FIH at Tm,FIH and integrated heat capacities (using Eq. 2 
and coefficients in Table 2) according to the thermodynamic cycle 1-7 outlined in Figure 3. 
The resulting enthalpy of fusion at Tm,FII was obtained as: 
 


FIIm,
HFIm,
H
FIIm,
trans
HHHH )d()d()()(
)(
FI,L,FII,FI,FIm,
fus
FI
trans
trans
FIFII
FIIm,
fus
FII
T
T
pp
T
T
pp
TCCTCCTHTH
TH
  (3)                       
Having access to melting data as well as experimentally determined heat capacities of a solid 
form and its supercooled melt allows the thermodynamics of fusion to be estimated as functions 
of temperature. Approximating the difference in heat capacity between the melt and the solid 
by a linear function: 
)( m TTrqC p            (4) 
the equations for the Gibbs energy of fusion and its enthalpic and entropic component terms 
become:[9] 
)()()( fusfusfus TSTTHTG          (5) 
2
mmm
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      (6) 
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In Figure 4, the resulting thermodynamic functions of fusion are shown for the four polymorphs 
FIL, FIH, FII and FV. For the purpose of constructing this figure, FIL and FIH are treated as one 
polymorph with discontinuous enthalpy and entropy curves and a thermodynamic transition 
temperature equal to the kinetic transition temperature of 311.1 K (as observed with DSC).  
Qualitatively, the polymorphic stability relationship agrees with previously reported findings.[7] 
The Gibbs energy estimates of FIH and FII become equal at a temperature of 333 K. This value 
is somewhat below the estimate of Thirunahari et al.[7] of 353 K, which is based on a simplified 
extrapolation of solubility data in methanol. However, it should be noted that there is also a 
significant uncertainty associated with our estimated value, mainly resulting from the closeness 
of the two Gibbs energy isobars, but also from the lack of calorimetric data on the fusion of FII. 
The diagram also shows that FV is significantly less stable than the other polymorphs, and that 
this fact is maintained throughout the entire investigated temperature range. Furthermore, it is 
worth mentioning that, as a result of the considerable difference in the heat capacity between 
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FIL and FIH shown in Figure 2, the enthalpy and entropy curves of these polymorphs exhibit 
significant differences. Due to enthalpy-entropy compensation, however, the resulting effect on 
the slope of the Gibbs energy curve of FI is almost undetectable. 
Solubility of FII in pure organic solvents 
The solubility of FII between 278 K and 313 K is reported in Table 3 as mass fraction on solvent 
basis. Each value is taken as the mean of three samples, and given together with its associated 
standard error. The solubility of other polymorphs could not be measured within this 
temperature range with the gravimetric method used, due to transformation into the stable FII. 
In Figure 5 a), the experimental solubility data is shown as g solute per kg of solvent. In Figure 
5 b) the same data is shown in a van’t Hoff plot, i.e. as ln xeq vs. T-1, where xeq is the solubility 
mole fraction. Van’t Hoff plots are often used to linearly extrapolate solubility values to higher 
temperatures, and even for predicting melting points. However, linearity in a van’t Hoff plot is 
not to be expected,[10] and when it is occasionally observed it is the result of a cancelling out of 
the temperature dependences of the enthalpy of fusion of the pure solid and the solution activity 
coefficient.[11] The van’t Hoff curves of the solubility of FII in all investigated solvents are 
visibly non-linear. 
The solubility mole fraction, xeq, has been modelled with two functions. The first is a simple 
empirical function of three parameters, where T is the temperature (in units of K), Eq. 8. This 
empirical model is a conveniently simple method for obtaining solubility data by interpolation 
within the experimental temperature range, where it gives a good fit. 
3
2
2
1
eqln c
T
c
T
c
x           (8) 
The second model is a recently-proposed semi-empirical solubility regression equation,[10] the 
principle of which is the separation of the temperature dependence of the activity of the pure 
solid from that of the activity coefficient of the saturated solution. The solubility then becomes: 
eq
s
eqeqeq lnlnlnlnln   aax          (9) 
aeq is the activity of the solute in a saturated solution, which becomes equal to the activity of 
the pure solid, as, provided that the same reference state is used. Choosing the pure, supercooled 
melt at the same temperature as the reference state, and modelling the heat capacity difference 
between the supercooled melt and the solid by Eq. 4, leads to: 
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The activity coefficient in the saturated solution is expressed as: 
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Eq. 11 obeys thermodynamic boundary conditions at the melting point.[10]. Consequently, the 
combination of Eq. 10 and Eq. 11 according to Eq. 9 results in an expression which obeys 
thermodynamic boundary conditions for the solubility mole fraction at the melting point. This 
makes it an appropriate model for correlating solubility data for purposes of extrapolation 
outside the experimental temperature range.[10] The regression coefficients of Eq. 8 and Eq. 11, 
obtained from a least-squares fit using the software OriginPro 8 (Origin Lab), are provided in 
Table 3.  
In Figure 5 c), the activity coefficients obtained using experimental solubility data and the 
activity of the pure solid are shown together with the regression curves obtained using Eq. (11) 
and the coefficients in Table 3. In all solvents at all investigated temperatures, the activity 
coefficient at saturation is well above unity. This considerable positive deviation from Raoult’s 
law indicates that none of the solvents is able to form sufficiently favorable interactions with 
the tolbutamide molecule. Tolbutamide is able to both donate and accept hydrogen bonds. 
Indeed, in the FII structure, each tolbutamide molecule participates in six hydrogen bonds with 
its neighbors, showing the importance of this kind of interaction. The departure from ideal 
behavior is by far the greatest in toluene, with the other four solvents resulting in approximately 
equal values of the activity coefficient at saturation. All the solvents are able, at least to some 
extent, to accept hydrogen bonds, although acetonitrile is a comparatively weak electron donor, 
as is the aromatic ring of toluene.[12] Neither toluene nor ethyl acetate are able to donate protons, 
however. Out of these two solvents, ethyl acetate shares a stronger chemical similarity with the 
tolbutamide molecule, having a polar group in the center surrounded by non-polar regions. 
Toluene is also unique in being the only essentially non-polar solvent evaluated. This, together 
with its poor ability to take part in hydrogen bonding with the solute molecules, is likely the 
explanation for the relatively high values of the activity coefficient observed in toluene. 
CONCLUSIONS 
The melting temperature and the associated enthalpy of fusion of tolbutamide FIH have been 
determined to be 400.3 ± 0.14 K and 27.56 ± 0.092 kJ/mol, respectively. The enthalpy of 
transition from FIL to FIH at 311.1 K has been measured to be 2.52 ± 0.010 kJ/mol. The melting 
temperature and the associated enthalpy of fusion of FV have been determined to be 375.73 ± 
0.051 K and 19.66 ± 0.088 kJ/mol, respectively. The heat capacities of FIH, FIH, FII and the 
supercooled melt are well described by linear functions of temperature. Through a 
thermodynamic cycle the enthalpy of fusion of FII at its reported melting point of 390 K has 
been calculated to be 28.3 kJ/mol. Through a comprehensive and quantitative analysis of 
experimental calorimetric data, the Gibbs energy, enthalpy and entropy of fusion are calculated 
for FIL+FIH, FII and FV up to the respective melting points. This data shows that the Gibbs 
energy of FII is the lowest of the evaluated polymorphs below approx. 333 K, above which 
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temperature FIH is the stable polymorph until its melting point. The relative stability of FV is 
below that of the other forms throughout the investigated temperature range. 
The solubility mole fraction of FII is significantly lower in toluene than in the evaluated 
aliphatic alcohols, ethyl acetate and acetonitrile. In all these solvents there is a positive deviation 
from Raoult’s law, with activity coefficients at saturation ranging between 33 and 80 in toluene 
and between 3 and 10 in the other four solvents, over the evaluated temperature range. It is 
shown that the contribution from the difference in heat capacity between the solid and the melt 
to the enthalpy of fusion of all the polymorphs, and to the ideal solubility of FII, is non- 
negligible.  
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